Excellent Safety Profiles

Airmid

Phone: (650) 368 6983
info@airmid.com

Target Portfolio >> Excellent Safety Profiles

PAP-1:

6-month daily oral administration at 50 mg/kg/day in rats.
28-day daily oral administration at 25 mg/kg/day in non-human primates.

ShK-186:

28-day daily subcutaneous injections at 500 mg/kg/day.

No behavioral, organ, blood cell or blood chemistry toxicity observed.

October 2006

AIRMID receives Series A
financing from Biotechnology
Value Fund.

more...